Blog

The intratumoral microbiome in lung cancer

Photo from Arielle Elkrief/X

Aug 11, 2024, 10:29

The intratumoral microbiome in lung cancer

Sumanta K. Pal shared a post on X:

“HUGE congrats to Arielle Elkrief, Smruthy Sivakumar, Marc Ladanyi, Charles Rudin, Chad Vanderbilt, and the exceptional teams at Memorial Sloan Kettering Cancer Center, Foundation Medicine and Flatiron Health that put together this massive effort in Journal of Clinical Oncology, characterizing the intratumoral microbiome in lung cancer. While indeed a controversial field I am impressed at the levels of clinical & pathologic validation demonstrated here at Andrea Necchi and Jonathan Friedberg.”

Source: Sumanta K. Pal/X

Sumanta (Monty) Pal, MD, is a medical oncologist and an expert in genitourinary cancers at the City of Hope Comprehensive Cancer Center in Los Angeles. He serves as the Vice Chair of Academic Affairs, Professor and co-director of the Kidney Cancer Program and leads the Kidney and Bladder Cancer Disease Team at City of Hope. He specialises in kidney, bladder, and prostate cancers.

Andrea Necchi Arielle Elkrief cancer Chad Vanderbilt Charles Rudin Flatiron Health Foundation Medicine intratumoral microbiome Jonathan Friedberg Journal of Clinical Oncology Lung cancer Marc Ladanyi Memorial Sloan Kettering Cancer Center OncoDaily Oncology Smruthy Sivakumar Sumanta K. Pal

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage